Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Annamaria Offidani and Federico Diotallevi.
Annamaria Offidani
Connection Strength
8.505
Federico Diotallevi
  1. Vaccines for COVID-19 in patients with atopic dermatitis: three things every dermatologist should know. Acta Dermatovenerol Alp Pannonica Adriat. 2021 Jun; 30(2):67-69.
    View in: PubMed
    Score: 0.948
  2. Vaccination against SARS-CoV-2 and psoriasis: the three things every dermatologist should know. J Eur Acad Dermatol Venereol. 2021 Jul; 35(7):e428-e430.
    View in: PubMed
    Score: 0.940
  3. Time to restart: protocol of resumption of activities of a dermatological clinic of a level II hospital in the COVID-19 era. Int J Dermatol. 2020 Nov; 59(11):1411-1413.
    View in: PubMed
    Score: 0.904
  4. Management of patients with pemphigus vulgaris during the COVID-19 pandemic: Experience of a second level dermatology center. Australas J Dermatol. 2021 02; 62(1):e158-e159.
    View in: PubMed
    Score: 0.896
  5. Hydroxychloroquine, dermatology, and SARS-CoV-2: Updating an old association. J Med Virol. 2021 01; 93(1):5-7.
    View in: PubMed
    Score: 0.895
  6. Skin involvement in SARS-CoV-2 infection: Case series. J Med Virol. 2020 11; 92(11):2332-2334.
    View in: PubMed
    Score: 0.885
  7. Ixekizumab for treatment of moderate to severe plaque psoriasis: real world clinical experience. G Ital Dermatol Venereol. 2020 Dec; 155(6):739-743.
    View in: PubMed
    Score: 0.794
  8. Recommendations for dermatologists treating patients with atopic dermatitis during the Covid-19 pandemic: a look into the past for a conscious vaccination management. Hum Vaccin Immunother. 2021 Oct 03; 17(10):3268-3275.
    View in: PubMed
    Score: 0.238
  9. Safety and Efficacy of Vaccines during COVID-19 Pandemic in Patients Treated with Biological Drugs in a Dermatological Setting. Healthcare (Basel). 2021 Apr 01; 9(4).
    View in: PubMed
    Score: 0.234
  10. Telogen effluvium related to post severe Sars-Cov-2 infection: Clinical aspects and our management experience. Dermatol Ther. 2021 Jan; 34(1):e14547.
    View in: PubMed
    Score: 0.229
  11. Management of patients with hidradenitis suppurativa during the COVID-19 pandemic: Risk and benefit of immunomodulatory therapy. Dermatol Ther. 2020 Nov; 33(6):e14256.
    View in: PubMed
    Score: 0.226
  12. Active implications for dermatologists in 'SARS-CoV-2 ERA': Personal experience and review of literature. J Eur Acad Dermatol Venereol. 2020 Aug; 34(8):1626-1632.
    View in: PubMed
    Score: 0.224
  13. How can I take care of you? The dermatologist meets patients' needs during the COVID-19 pandemic. Dermatol Ther. 2020 Jul; 33(4):e13740.
    View in: PubMed
    Score: 0.222
  14. Global coronavirus pandemic (SARS-CoV-2): Past, present, and future of pediatric dermatology. Dermatol Ther. 2020 09; 33(5):e13767.
    View in: PubMed
    Score: 0.222
  15. Global coronavirus pandemic (2019-nCOV): implication for an Italian medium size dermatological clinic of a II level hospital. J Eur Acad Dermatol Venereol. 2020 05; 34(5):e213-e214.
    View in: PubMed
    Score: 0.220
  16. Familial lupus panniculitis: two cases, same diagnosis, what evolution? G Ital Dermatol Venereol. 2020 Dec; 155(6):791-793.
    View in: PubMed
    Score: 0.201
  17. Granuloma faciale successfully treated with ingenol mebutate. Dermatol Ther. 2016 Sep; 29(5):325-329.
    View in: PubMed
    Score: 0.169
  18. A multicenter study on effectiveness and safety of risankizumab in psoriasis: an Italian 16-week real-life experience during the COVID-19 pandemic. J Eur Acad Dermatol Venereol. 2021 Mar; 35(3):e169-e170.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.